{"draw":1,"recordsFiltered":12778,"recordsTotal":12778,"data":[{"__attributes":{"id":"post-row-86162","class":"post-row post-type-post post-86162 publish"},"date":" 16 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780.png\" class=\"\" alt=\"FDA Advisory No.2024-0780 || Transitory Provisions relative to FDA Advisory 2023-0258 dated 15 February 2023\" loading=\"lazy\" title=\"FDA Advisory No.2024-0780\" data-caption=\"FDA Advisory No.2024-0780 || Transitory Provisions relative to FDA Advisory 2023-0258 dated 15 February 2023\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0780-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0780-transitory-provisions-relative-to-fda-advisory-2023-0258-dated-15-february-2023\/\">FDA Advisory No.2024-0780 || Transitory Provisions relative to FDA Advisory 2023-0258 dated 15 February 2023<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86131","class":"post-row post-type-post post-86131 publish"},"date":" 15 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0772-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0772-A\" data-caption=\"FDA Advisory No.2024-0772-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0772-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0772-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86127","class":"post-row post-type-post post-86127 publish"},"date":" 15 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772.png\" class=\"\" alt=\"FDA Advisory No.2024-0772 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0772\" data-caption=\"FDA Advisory No.2024-0772 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0772-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0772-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0772 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86123","class":"post-row post-type-post post-86123 publish"},"date":" 15 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0771-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na \u201cFairwin Freedom &amp; Wellness Feel Well Rub 15gms.\u201d\" loading=\"lazy\" title=\"DA Advisory No.2024-0771-A\" data-caption=\"FDA Advisory No.2024-0771-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na \u201cFairwin Freedom &amp; Wellness Feel Well Rub 15gms.\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/DA-Advisory-No.2024-0771-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0771-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-na-fairwin-freedom-wellness-feel-well-rub-15gms\/\">FDA Advisory No.2024-0771-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na \u201cFairwin Freedom &#038; Wellness Feel Well Rub 15gms.\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86119","class":"post-row post-type-post post-86119 publish"},"date":" 15 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771.png\" class=\"\" alt=\"FDA Advisory No.2024-0771 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cFairwin Freedom &amp; Wellness Feel Well Rub 15gms.\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0771\" data-caption=\"FDA Advisory No.2024-0771 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cFairwin Freedom &amp; Wellness Feel Well Rub 15gms.\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0771-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0771-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-fairwin-freedom-wellness-feel-well-rub-15gms\/\">FDA Advisory No.2024-0771 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cFairwin Freedom &#038; Wellness Feel Well Rub 15gms.\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86115","class":"post-row post-type-post post-86115 publish"},"date":" 15 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0770-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cS-Nature Hilbas Plus Herbal Oil 30mL\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0770-A\" data-caption=\"FDA Advisory No.2024-0770-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cS-Nature Hilbas Plus Herbal Oil 30mL\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0770-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-s-nature-hilbas-plus-herbal-oil-30ml\/\">FDA Advisory No.2024-0770-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cS-Nature Hilbas Plus Herbal Oil 30mL\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86109","class":"post-row post-type-post post-86109 publish"},"date":" 15 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770.png\" class=\"\" alt=\"FDA Advisory No.2024-0770 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cS-Nature Hilbas Plus Herbal Oil 30mL \u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0770\" data-caption=\"FDA Advisory No.2024-0770 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cS-Nature Hilbas Plus Herbal Oil 30mL \u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0770-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0770-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-s-nature-hilbas-plus-herbal-oil-30ml\/\">FDA Advisory No.2024-0770 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cS-Nature Hilbas Plus Herbal Oil 30mL \u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86077","class":"post-row post-type-post post-86077 publish"},"date":" 14 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767.png\" class=\"\" alt=\"FDA Advisory No.2024-0767 || Public Health Warning Against the Purchase and Use of Household Urban Hazardous Substances (HUHS) Product STANDARD AEROSOL SPRAY PAINT 14 (JIALING RED) Containing Toxic Levels of Heavy Metal\/s\" loading=\"lazy\" title=\"FDA Advisory No.2024-0767\" data-caption=\"FDA Advisory No.2024-0767 || Public Health Warning Against the Purchase and Use of Household Urban Hazardous Substances (HUHS) Product STANDARD AEROSOL SPRAY PAINT 14 (JIALING RED) Containing Toxic Levels of Heavy Metal\/s\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0767-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0767-public-health-warning-against-the-purchase-and-use-of-household-urban-hazardous-substances-huhs-product-standard-aerosol-spray-paint-14-jialing-red-containing-toxic-le\/\">FDA Advisory No.2024-0767 || Public Health Warning Against the Purchase and Use of Household Urban Hazardous Substances (HUHS) Product STANDARD AEROSOL SPRAY PAINT 14 (JIALING RED) Containing Toxic Levels of Heavy Metal\/s<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86073","class":"post-row post-type-post post-86073 publish"},"date":" 14 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766.png\" class=\"\" alt=\"FDA Advisory No.2024-0766 || Public Health Warning Against the Purchase and Use of Household Urban Hazardous Substances (HUHS) Product CHAPPIE SPRAY PAINT 14 ORANGE RED Containing Toxic Levels of Heavy Metal\/s\" loading=\"lazy\" title=\"FDA Advisory No.2024-0766\" data-caption=\"FDA Advisory No.2024-0766 || Public Health Warning Against the Purchase and Use of Household Urban Hazardous Substances (HUHS) Product CHAPPIE SPRAY PAINT 14 ORANGE RED Containing Toxic Levels of Heavy Metal\/s\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0766-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0766-public-health-warning-against-the-purchase-and-use-of-household-urban-hazardous-substances-huhs-product-chappie-spray-paint-14-orange-red-containing-toxic-levels-of-heav\/\">FDA Advisory No.2024-0766 || Public Health Warning Against the Purchase and Use of Household Urban Hazardous Substances (HUHS) Product CHAPPIE SPRAY PAINT 14 ORANGE RED Containing Toxic Levels of Heavy Metal\/s<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86069","class":"post-row post-type-post post-86069 publish"},"date":" 14 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765.png\" class=\"\" alt=\"FDA Advisory No.2024-0765 || Public Health Warning Against the Purchase and Use of Household Urban Hazardous Substances (HUHS) Product NIKKO SPRAY ALL PURPOSE QUICK DRYING HIGH GLOSS ACRYLIC 164 GRASS GREEN Containing Toxic Levels of Heavy Metal\/s\" loading=\"lazy\" title=\"FDA Advisory No.2024-0765\" data-caption=\"FDA Advisory No.2024-0765 || Public Health Warning Against the Purchase and Use of Household Urban Hazardous Substances (HUHS) Product NIKKO SPRAY ALL PURPOSE QUICK DRYING HIGH GLOSS ACRYLIC 164 GRASS GREEN Containing Toxic Levels of Heavy Metal\/s\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0765-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0765-public-health-warning-against-the-purchase-and-use-of-household-urban-hazardous-substances-huhs-product-nikko-spray-all-purpose-quick-drying-high-gloss-acrylic-164-grass\/\">FDA Advisory No.2024-0765 || Public Health Warning Against the Purchase and Use of Household Urban Hazardous Substances (HUHS) Product NIKKO SPRAY ALL PURPOSE QUICK DRYING HIGH GLOSS ACRYLIC 164 GRASS GREEN Containing Toxic Levels of Heavy Metal\/s<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86065","class":"post-row post-type-post post-86065 publish"},"date":" 14 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764.png\" class=\"\" alt=\"FDA Advisory No.2024-0764 || Public Health Warning Against the Purchase and Use of Cosmetic Product THE PORCELANA ASTRINGENT PLUS PORCELANA\u00ae Containing Banned Ingredient\/\" loading=\"lazy\" title=\"FDA Advisory No.2024-0764\" data-caption=\"FDA Advisory No.2024-0764 || Public Health Warning Against the Purchase and Use of Cosmetic Product THE PORCELANA ASTRINGENT PLUS PORCELANA\u00ae Containing Banned Ingredient\/\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0764-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0764-public-health-warning-against-the-purchase-and-use-of-cosmetic-product-the-porcelana-astringent-plus-porcelana-containing-banned-ingredient\/\">FDA Advisory No.2024-0764 || Public Health Warning Against the Purchase and Use of Cosmetic Product THE PORCELANA ASTRINGENT PLUS PORCELANA\u00ae Containing Banned Ingredient\/<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86060","class":"post-row post-type-post post-86060 publish"},"date":" 14 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763.png\" class=\"\" alt=\"FDA Advisory No.2024-0763 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic Product SKIN PERFECTION REJUVENATING TONER FACIAL CLEANSER Containing Banned Ingredient\/s\" loading=\"lazy\" title=\"FDA Advisory No.2024-0763\" data-caption=\"FDA Advisory No.2024-0763 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic Product SKIN PERFECTION REJUVENATING TONER FACIAL CLEANSER Containing Banned Ingredient\/s\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0763-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0763-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-product-skin-perfection-rejuvenating-toner-facial-cleanser-containing-banned-ingredient-s\/\">FDA Advisory No.2024-0763 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic Product SKIN PERFECTION REJUVENATING TONER FACIAL CLEANSER Containing Banned Ingredient\/s<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86055","class":"post-row post-type-post post-86055 publish"},"date":" 14 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762.png\" class=\"\" alt=\"FDA Advisory No.2024-0762 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic Product BEAUTYWISE REJUVENATING TONER Containing Banned Ingredient\/s\" loading=\"lazy\" title=\"FDA Advisory No.2024-0762\" data-caption=\"FDA Advisory No.2024-0762 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic Product BEAUTYWISE REJUVENATING TONER Containing Banned Ingredient\/s\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0762-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0762-public-health-warning-against-the-purchase-and-use-of-unauthorized-cosmetic-product-beautywise-rejuvenating-toner-containing-banned-ingredient-s\/\">FDA Advisory No.2024-0762 || Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic Product BEAUTYWISE REJUVENATING TONER Containing Banned Ingredient\/s<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86035","class":"post-row post-type-post post-86035 publish"},"date":" 14 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0758-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cFluocinonide Cream 20g:5mg\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0758-A\" data-caption=\"FDA Advisory No.2024-0758-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cFluocinonide Cream 20g:5mg\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0758-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-fluocinonide-cream-20g5mg\/\">FDA Advisory No.2024-0758-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cFluocinonide Cream 20g:5mg\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86030","class":"post-row post-type-post post-86030 publish"},"date":" 14 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758.png\" class=\"\" alt=\"FDA Advisory No.2024-0758 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cFluocinonide Cream 20g:5mg\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0758\" data-caption=\"FDA Advisory No.2024-0758 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cFluocinonide Cream 20g:5mg\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0758-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0758-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-fluocinonide-cream-20g5mg\/\">FDA Advisory No.2024-0758 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cFluocinonide Cream 20g:5mg\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86026","class":"post-row post-type-post post-86026 publish"},"date":" 14 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0755-A ||  Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na \u201cKidneys Nano 20 Effervescent\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0755-A\" data-caption=\"FDA Advisory No.2024-0755-A ||  Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na \u201cKidneys Nano 20 Effervescent\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0755-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-na-kidneys-nano-20-effervescent\/\">FDA Advisory No.2024-0755-A ||  Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot na \u201cKidneys Nano 20 Effervescent\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86020","class":"post-row post-type-post post-86020 publish"},"date":" 13 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\" class=\"\" alt=\"FDA Advisory No.2024-0755 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cKidneys Nano 20 Effervescent\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0755\" data-caption=\"FDA Advisory No.2024-0755 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cKidneys Nano 20 Effervescent\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0755-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0755-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-kidneys-nano-20-effervescent\/\">FDA Advisory No.2024-0755 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cKidneys Nano 20 Effervescent\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86016","class":"post-row post-type-post post-86016 publish"},"date":" 13 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\" class=\"\" alt=\"FDA Advisory No.2024-0769 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cMAXWELL LATEX EXAMINATION GLOVES\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0769\" data-caption=\"FDA Advisory No.2024-0769 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cMAXWELL LATEX EXAMINATION GLOVES\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0769-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0769-public-health-warning-against-the-purchase-and-use-of-the-unnotified-medical-device-product-maxwell-latex-examination-gloves\/\">FDA Advisory No.2024-0769 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cMAXWELL LATEX EXAMINATION GLOVES\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/device-advisories\/\" rel=\"category tag\">Device Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-86011","class":"post-row post-type-post post-86011 publish"},"date":" 13 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\" class=\"\" alt=\"FDA Advisory No.2024-0768 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cSAMPLE LINE, 8 FT. (2.4M)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0768\" data-caption=\"FDA Advisory No.2024-0768 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cSAMPLE LINE, 8 FT. (2.4M)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0768-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0768-public-health-warning-against-the-purchase-and-use-of-the-unnotified-medical-device-product-sample-line-8-ft-2-4m\/\">FDA Advisory No.2024-0768 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product \u201cSAMPLE LINE, 8 FT. (2.4M)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/device-advisories\/\" rel=\"category tag\">Device Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85973","class":"post-row post-type-post post-85973 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\" class=\"\" alt=\"FDA Advisory No.2024-0761 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Sleep Vitamins (Dietary Supplement)&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0761\" data-caption=\"FDA Advisory No.2024-0761 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Sleep Vitamins (Dietary Supplement)&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0761-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0761-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-supplement-vitabears-sleep-vitamins-dietary-supplement\/\">FDA Advisory No.2024-0761 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Sleep Vitamins (Dietary Supplement)&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85969","class":"post-row post-type-post post-85969 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\" class=\"\" alt=\"FDA Advisory No.2024-0760 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Skin Vitamins (Dietary Supplement)&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0760\" data-caption=\"FDA Advisory No.2024-0760 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Skin Vitamins (Dietary Supplement)&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0760-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0760-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-supplement-vitabears-skin-vitamins-dietary-supplement\/\">FDA Advisory No.2024-0760 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Skin Vitamins (Dietary Supplement)&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85965","class":"post-row post-type-post post-85965 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\" class=\"\" alt=\"FDA Advisory No.2024-0759 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Flawless Glow (Dietary Supplement)&quot;\" loading=\"lazy\" title=\"FDA Advisory No.2024-0759\" data-caption=\"FDA Advisory No.2024-0759 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Flawless Glow (Dietary Supplement)&quot;\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0759-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0759-public-health-warning-against-the-purchase-and-consumption-of-the-unregistered-food-supplement-vitabears-flawless-glow-dietary-supplement\/\">FDA Advisory No.2024-0759 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Supplement \u201cVITABEARS Flawless Glow (Dietary Supplement)&#8221;<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/food-advisories\/\" rel=\"category tag\">Food Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85961","class":"post-row post-type-post post-85961 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0757-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0757-A\" data-caption=\"FDA Advisory No.2024-0757-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0757-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0757-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85957","class":"post-row post-type-post post-85957 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\" class=\"\" alt=\"FDA Advisory No.2024-0757 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0757\" data-caption=\"FDA Advisory No.2024-0757 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0757-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0757-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0757 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85953","class":"post-row post-type-post post-85953 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0756-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0756-A\" data-caption=\"FDA Advisory No.2024-0756-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0756-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0756-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85949","class":"post-row post-type-post post-85949 publish"},"date":" 9 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\" class=\"\" alt=\"FDA Advisory No.2024-0756 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0756\" data-caption=\"FDA Advisory No.2024-0756 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0756-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0756-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0756 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85942","class":"post-row post-type-post post-85942 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0752-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNatural Eye Drops 15 mL (250 drops)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0752-A\" data-caption=\"FDA Advisory No.2024-0752-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNatural Eye Drops 15 mL (250 drops)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0752-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-natural-eye-drops-15-ml-250-drops\/\">FDA Advisory No.2024-0752-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNatural Eye Drops 15 mL (250 drops)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85938","class":"post-row post-type-post post-85938 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\" class=\"\" alt=\"FDA Advisory No.2024-0752 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNatural Eye Drops 15 mL (250 drops)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0752\" data-caption=\"FDA Advisory No.2024-0752 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNatural Eye Drops 15 mL (250 drops)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0752-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0752-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-natural-eye-drops-15-ml-250-drops\/\">FDA Advisory No.2024-0752 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNatural Eye Drops 15 mL (250 drops)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85934","class":"post-row post-type-post post-85934 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0751-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0751-A\" data-caption=\"FDA Advisory No.2024-0751-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0751-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-glutax-4000gs-cell-rejuvenation-softgel-60s\/\">FDA Advisory No.2024-0751-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85930","class":"post-row post-type-post post-85930 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\" class=\"\" alt=\"FDA Advisory No.2024-0751 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0751\" data-caption=\"FDA Advisory No.2024-0751 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0751-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0751-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-glutax-4000gs-cell-rejuvenation-softgel-60s\/\">FDA Advisory No.2024-0751 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cGlutax\u00ae 4000GS Cell Rejuvenation Softgel 60\u2019s\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85926","class":"post-row post-type-post post-85926 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0750-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0750-A\" data-caption=\"FDA Advisory No.2024-0750-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0750-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-partners-alcohol-pads-75-ethyl-alcohol\/\">FDA Advisory No.2024-0750-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85922","class":"post-row post-type-post post-85922 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\" class=\"\" alt=\"FDA Advisory No.2024-0750 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0750\" data-caption=\"FDA Advisory No.2024-0750 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0750-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0750-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-partners-alcohol-pads-75-ethyl-alcohol\/\">FDA Advisory No.2024-0750 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cPartners\u00ae Alcohol Pads 75% Ethyl Alcohol\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85907","class":"post-row post-type-post post-85907 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0754-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201c1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0754-A\" data-caption=\"FDA Advisory No.2024-0754-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201c1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0754-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-1500i-u-0-75ml-solution-for-injection-i-m-s-c\/\">FDA Advisory No.2024-0754-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201c1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85900","class":"post-row post-type-post post-85900 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\" class=\"\" alt=\"FDA Advisory No.2024-0754 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cTetanus Antitoxin 1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0754\" data-caption=\"FDA Advisory No.2024-0754 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cTetanus Antitoxin 1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0754-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0754-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-tetanus-antitoxin-1500i-u-0-75ml-solution-for-injection-i-m-s-c\/\">FDA Advisory No.2024-0754 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cTetanus Antitoxin 1500I.U.\/0.75ML Solution for Injection (I.M.\/S.C.)\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85895","class":"post-row post-type-post post-85895 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0753-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0753-A\" data-caption=\"FDA Advisory No.2024-0753-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0753-a-babala-sa-publiko-tungkol-sa-paggamit-ng-beripikadong-pekeng-gamot-na-anti-rabies-serum-equine-equirab-200-iu-ml-1000-iu-5ml-solution-for-injection-i-m\/\">FDA Advisory No.2024-0753-A || Babala sa Publiko tungkol sa Paggamit ng Beripikadong Pekeng Gamot na \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85890","class":"post-row post-type-post post-85890 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\" class=\"\" alt=\"FDA Advisory No.2024-0753 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0753\" data-caption=\"FDA Advisory No.2024-0753 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0753-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0753-public-health-warning-against-the-purchase-and-use-of-the-counterfeit-drug-product-anti-rabies-serum-equine-equirab-200-iu-ml-1000-iu-5ml-solution-for-injec\/\">FDA Advisory No.2024-0753 || Public Health Warning Against the Purchase and Use of the Counterfeit Drug Product \u201cAnti-Rabies Serum (Equine) (Equirab) 200 IU\/mL (1000 IU\/5mL) Solution for Injection (I.M.\/S.C.) 5 mL Vial\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85861","class":"post-row post-type-post post-85861 publish"},"date":" 8 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\" class=\"\" alt=\"FDA Advisory No.2024-0749 || Pest Control Operators (PCO) Regulatory Updates\" loading=\"lazy\" title=\"FDA Advisory No.2024-0749\" data-caption=\"FDA Advisory No.2024-0749 || Pest Control Operators (PCO) Regulatory Updates\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0749-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0749-pest-control-operators-pco-regulatory-updates\/\">FDA Advisory No.2024-0749 || Pest Control Operators (PCO) Regulatory Updates<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/cosmetic-advisories\/\" rel=\"category tag\">Cosmetic Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85830","class":"post-row post-type-post post-85830 publish"},"date":" 7 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\" class=\"\" alt=\"FDA Advisory No.2024-0748 || Pilot Implementation of the Electronic Certificate of Product Registration (E-CPR) Information System for the Application for Initial Registration of Generic Prescription Drugs for Human Use from 07 May 2024 to 07 August 2024\" loading=\"lazy\" title=\"FDA Advisory No.2024-0748\" data-caption=\"FDA Advisory No.2024-0748 || Pilot Implementation of the Electronic Certificate of Product Registration (E-CPR) Information System for the Application for Initial Registration of Generic Prescription Drugs for Human Use from 07 May 2024 to 07 August 2024\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0748-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0748-pilot-implementation-of-the-electronic-certificate-of-product-registration-e-cpr-information-system-for-the-application-for-initial-registration-of-generic-prescription\/\">FDA Advisory No.2024-0748 || Pilot Implementation of the Electronic Certificate of Product Registration (E-CPR) Information System for the Application for Initial Registration of Generic Prescription Drugs for Human Use from 07 May 2024 to 07 August 2024<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85825","class":"post-row post-type-post post-85825 publish"},"date":" 7 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\" class=\"\" alt=\"FDA Advisory No.2024-0573 || Call for Nomination as member of the Animal Health Product Advisory Committee (AHPAC)\" loading=\"lazy\" title=\"FDA Advisory No.2024-0573\" data-caption=\"FDA Advisory No.2024-0573 || Call for Nomination as member of the Animal Health Product Advisory Committee (AHPAC)\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0573-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0573-call-for-nomination-as-member-of-the-animal-health-product-advisory-committee-ahpac\/\">FDA Advisory No.2024-0573 || Call for Nomination as member of the Animal Health Product Advisory Committee (AHPAC)<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85821","class":"post-row post-type-post post-85821 publish"},"date":" 7 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\" class=\"\" alt=\"FDA Advisory No.2024-0558 || Call for Nomination as member of the Human Drug Registration Advisory Committee (HDRAC)\" loading=\"lazy\" title=\"FDA Advisory No.2024-0558\" data-caption=\"FDA Advisory No.2024-0558 || Call for Nomination as member of the Human Drug Registration Advisory Committee (HDRAC)\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0558-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0558-call-for-nomination-as-member-of-the-human-drug-registration-advisory-committee-hdrac\/\">FDA Advisory No.2024-0558 || Call for Nomination as member of the Human Drug Registration Advisory Committee (HDRAC)<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85802","class":"post-row post-type-post post-85802 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0747-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cOTC Erythromycin Ointment 5g\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0747-A\" data-caption=\"FDA Advisory No.2024-0747-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cOTC Erythromycin Ointment 5g\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0747-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-otc-erythromycin-ointment-5g\/\">FDA Advisory No.2024-0747-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cOTC Erythromycin Ointment 5g\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85798","class":"post-row post-type-post post-85798 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\" class=\"\" alt=\"FDA Advisory No.2024-0747 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cOTC Erythromycin Ointment 5g\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0747\" data-caption=\"FDA Advisory No.2024-0747 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cOTC Erythromycin Ointment 5g\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0747-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0747-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-otc-erythromycin-ointment-5g\/\">FDA Advisory No.2024-0747 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cOTC Erythromycin Ointment 5g\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85792","class":"post-row post-type-post post-85792 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0746-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0746-A\" data-caption=\"FDA Advisory No.2024-0746-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0746-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0746-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85786","class":"post-row post-type-post post-85786 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\" class=\"\" alt=\"FDA Advisory No.2024-0746 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0746\" data-caption=\"FDA Advisory No.2024-0746 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0746-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0746-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0746 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85780","class":"post-row post-type-post post-85780 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0745-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0745-A\" data-caption=\"FDA Advisory No.2024-0745-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0745-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0745-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85774","class":"post-row post-type-post post-85774 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\" class=\"\" alt=\"FDA Advisory No.2024-0745 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0745\" data-caption=\"FDA Advisory No.2024-0745 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0745-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0745-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0745 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85770","class":"post-row post-type-post post-85770 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0744-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNANZ i-Drops 15ml\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0744-A\" data-caption=\"FDA Advisory No.2024-0744-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNANZ i-Drops 15ml\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0744-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-hindi-rehistradong-gamot-nanz-i-drops-15ml\/\">FDA Advisory No.2024-0744-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Hindi Rehistradong Gamot \u201cNANZ i-Drops 15ml\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85766","class":"post-row post-type-post post-85766 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\" class=\"\" alt=\"FDA Advisory No.2024-0744 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNANZ i-Drops 15mL\u201d\" loading=\"lazy\" title=\"FDA Advisory No.2024-0744\" data-caption=\"FDA Advisory No.2024-0744 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNANZ i-Drops 15mL\u201d\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0744-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0744-public-health-warning-against-the-purchase-and-use-of-the-unregistered-drug-product-nanz-i-drops-15ml\/\">FDA Advisory No.2024-0744 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product \u201cNANZ i-Drops 15mL\u201d<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85760","class":"post-row post-type-post post-85760 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\" class=\"\" alt=\"FDA Advisory No.2024-0743-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0743-A\" data-caption=\"FDA Advisory No.2024-0743-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-A-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0743-a-babala-sa-publiko-tungkol-sa-pagbili-at-paggamit-ng-mga-sumusunod-na-hindi-rehistradong-gamot\/\">FDA Advisory No.2024-0743-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""},{"__attributes":{"id":"post-row-85754","class":"post-row post-type-post post-85754 publish"},"date":" 6 May 2024","image":"<div style=\"width:400px;\" data-thumb=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\" class=\"posts-table-image-wrapper posts-table-gallery__image\"><a href=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\"><img width=\"400\" height=\"225\" src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\" class=\"\" alt=\"FDA Advisory No.2024-0743 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" loading=\"lazy\" title=\"FDA Advisory No.2024-0743\" data-caption=\"FDA Advisory No.2024-0743 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:\" data-src=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\" data-large_image=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png\" data-large_image_width=\"4417\" data-large_image_height=\"2480\" srcset=\"https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743.png 4417w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-300x168.png 300w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-1024x575.png 1024w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-768x431.png 768w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-1536x862.png 1536w, https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2024\/05\/FDA-Advisory-No.2024-0743-2048x1150.png 2048w\" sizes=\"(max-width: 400px) 100vw, 400px\" \/><\/a><\/div>","title":"<a href=\"https:\/\/www.fda.gov.ph\/fda-advisory-no-2024-0743-public-health-warning-against-the-purchase-and-use-of-the-following-unregistered-drug-products\/\">FDA Advisory No.2024-0743 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:<\/a>","categories":"<a href=\"https:\/\/www.fda.gov.ph\/category\/drugs-advisories\/\" rel=\"category tag\">Drugs Advisories<\/a>","categories_hfilter":""}]}
